Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma

被引：189
|
作者：
Liu, David [1 ]
Plimack, Elizabeth R.
Hoffman-Censits, Jean [3 ]
Garraway, Levi A. [1 ,2 ]
Bellmunt, Joaquim [1 ]
Van Allen, Eliezer [1 ,2 ]
Rosenberg, Jonathan E. [4 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Broad Inst Harvard & MIT, Cambridge, MA USA
[3] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 08期
关键词：
CISPLATIN SENSITIVITY; REPAIR;
D O I：
10.1001/jamaoncol.2016.1056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1094 / 1096
页数：4
相关论文
共 50 条
  • [1] Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
    Van Allen, Eliezer M.
    Mouw, Kent W.
    Kim, Philip
    Iyer, Gopa
    Wagle, Nikhil
    Al-Ahmadie, Hikmat
    Zhu, Cong
    Ostrovnaya, Irina
    Kryukov, Gregory V.
    O'Connor, Kevin W.
    Sfakianoss, John
    Garcia-Grossman, Ilana
    Kim, Jaegil
    Guancial, Elizabeth A.
    Bambury, Richard
    Bahl, Samira
    Gupta, Namrata
    Farlow, Deborah
    Qu, Angela
    Signoretti, Sabina
    Barletta, Justine A.
    Reuter, Victor
    Boehm, Jesse
    Lawrence, Michael
    Getz, Gad
    Kantoff, Philip
    Bochner, Bernard H.
    Choueiri, Toni K.
    Bajorin, Dean F.
    Solit, David B.
    Gabriel, Stacey
    D'Andrea, Alan
    Garraway, Levi A.
    Rosenberg, Jonathan E.
    CANCER DISCOVERY, 2014, 4 (10) : 1140 - 1153
  • [2] Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive urothelial carcinoma.
    Rosenberg, Jonathan E.
    Van Allen, Eliezer Mendel
    Mouw, Kent William
    Kim, Philip H.
    Wagle, Nikhil
    Al-Ahmadie, Hikmat
    Zhu, Cong
    Ostrovnaya, Irina
    Iyer, Gopa
    Signoretti, Sabina
    Reuter, Victor E.
    Getz, Gad
    Kantoff, Philip W.
    Bochner, Bernard H.
    Choueiri, Toni K.
    Bajorin, Dean F.
    Solit, David B.
    Gabriel, Stacey B.
    D'Andrea, Alan D.
    Garraway, Levi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Muscle-invasive urothelial carcinoma of the bladder
    Malkowicz, S. Bruce
    van Poppel, Hendrik
    Mickisch, Gerald
    Pansadoro, Vito
    Thuroff, Joachim
    Soloway, Mark S.
    Chang, Sam
    Benson, Mitchell
    Fukui, Iwao
    UROLOGY, 2007, 69 : 3 - 16
  • [4] Mapping the Functional Landscape of ERCC2 Mutations in Muscle-Invasive Bladder Cancer
    Frazier, Z.
    Damish, A.
    Reznichenko, E.
    Liu, D.
    Rosenberg, J.
    Van Allen, E.
    Lazaro, J. B.
    D'Andrea, A. D.
    Mouw, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S32 - S33
  • [5] Somatic ERCC2 Mutations Confer Cisplatin Sensitivity in Muscle-Invasive Urothelial Cancer
    Mouw, K.
    Van Allen, E.
    O'Connor, K.
    Wagle, N.
    Kim, P.
    Al-Ahmadie, H.
    Zhu, C.
    Ostravnaya, I.
    Iyer, G.
    Signoretti, S.
    Reuter, V.
    Getz, G.
    Kantoff, P. W.
    Bochner, B.
    Choueiri, T. K.
    Bajorin, D. F.
    Gabriel, S.
    D'Andrea, A.
    Garraway, L.
    Rosenberg, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S88 - S88
  • [6] Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder
    Mossanen, Matthew
    Lee, Franklin
    Cheng, Heather
    Harris, William
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael P.
    Yu, Evan Y.
    Wright, Jonathan L.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (03) : 210 - 213
  • [7] ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder Cancers
    Choi, Woonyoung
    McConkey, David J.
    EUROPEAN UROLOGY, 2019, 75 (02) : 240 - 241
  • [8] Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosis in muscle-invasive urothelial carcinoma of the bladder
    He, Ya-Di
    Luo, Zi-Huan
    Yang, Ming
    Ruan, Xing-Xing
    Liu, Shao-Yuan
    Wu, Zhen-Quan
    Deng, Wei-Ming
    Shao, Chun-Kui
    Su, Zu-Lan
    He, Dan
    Gao, Xin
    Li, Liao-Yuan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (03) : 416 - 423
  • [9] Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder
    Hensley, Patrick J.
    Goodwin, Jeffrey
    Davenport, Daniel L.
    Strup, Stephen E.
    James, Andrew
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E851 - E858
  • [10] Somatic ERCC2 Mutations Are Associated With a Distinct Mutational Signature in Muscle-Invasive Bladder Cancer
    Mouw, K.
    Braunstein, L. Z.
    Kim, J.
    Polak, P.
    Getz, G.
    D'Andrea, A. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S54 - S54
12345